Expand HCM Menu
HCM MENU

HCM Latest Press Releases

-- August 16, 2026 --

HUTCHMED Announces ORPATHYS Plus TAGRISSO Demonstrated Statistically Significant and Clinically Meaningful Improvements in Progression-Free and Overall Survival in MET-Driven EGFR-Mutated Lung Cancer After Progression on TAGRISSO Globe Newswire 8:00 PM

-- July 30, 2026 --

HUTCHMED Reports 2026 Interim Results Globe Newswire 7:00 AM

-- July 2, 2026 --

HUTCHMED Announces NMPA Approval for ORPATHYS for the treatment of Gastric Cancer Patients with MET Amplification Globe Newswire 4:30 AM

-- June 30, 2026 --

HUTCHMED to Announce 2026 Half-Year Financial Results Globe Newswire 4:30 AM

-- June 24, 2026 --

HUTCHMED Highlights Pivotal Phase II Data for Fanregratinib in Intrahepatic Cholangiocarcinoma Presented at ESMO Gastrointestinal Cancers Congress 2026 Globe Newswire 8:00 PM

-- June 11, 2026 --

HUTCHMED Highlights Sovleplenib ESLIM-02 Phase III Data in Warm Antibody Autoimmune Hemolytic Anemia Presented at EHA 2026 Congress Globe Newswire 8:00 PM

-- May 21, 2026 --

HUTCHMED Highlights Clinical Data to be Presented at the 2026 ASCO Annual Meeting Globe Newswire 8:00 PM

-- April 29, 2026 --

Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing Globe Newswire 8:44 AM
HUTCHMED Announces NDA Acceptance in China with Priority Review Status and Breakthrough Designation for Sovleplenib for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia Globe Newswire 6:00 AM

-- April 23, 2026 --

International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on April 28, 2026 Globe Newswire 8:35 AM

-- April 8, 2026 --

HUTCHMED Highlights Data to be Presented at AACR Annual Meeting 2026 Globe Newswire 8:00 PM
Market Data Delayed 15 Minutes